Subcutaneous Rehydration Compared to Intravenous Rehydration

PHASE4CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

December 31, 2009

Conditions
Dehydration
Interventions
DRUG

recombinant human hyaluronidase

150 Units in 1 mL

Trial Locations (25)

10305

Staten Island University Hospital Emergency Department, Staten Island

10956

Children's Hospital at Montefiore, The Bronx

11215

New York Methodist Hospital, Brooklyn

30322

Children's Healthcare of Atlanta, Atlanta

30342

Children's Healthcare of Atlanta - Scottish Rite, Atlanta

30721

North Georgia Clinical Research, Dalton

32806

Arnold Palmer Hospital for Children, Orlando

33606

Tampa General Hospital Children's Medical Center, Tampa

40202

University of Louisville, Louisville

44106

Rainbow Children's and Babies Hospital, Cleveland

44195

Cleveland Clinic Foundation, Cleveland

46601

Memorial Hospital, South Bend

48085

William Beaumont Hospital, Troy

60614

Children's Memorial Hospital, Chicago

64108

The Children's Mercy Hospital & Clinics, Kansas City

70121

Ochsner Clinic Foundation, New Orleans

75235

Children's Medical Center Dallas, Dallas

76104

Cook Children's Medical Center, Fort Worth

77030

Texas Children's Hospital, Houston

78723

Dell Children's Medical Center, Austin

87131

University of New Mexico Health Sciences Center, Albuquerque

97239

Oregon Health & Science University, Portland

06106

Connecticut Children's Medical Center, Hartford

08903

UMDNJ/Robert Wood Johnson Medical School, New Brunswick

07503

St. Joseph's Children's Hospital, Paterson

Sponsors
All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Halozyme Therapeutics

INDUSTRY

NCT00773175 - Subcutaneous Rehydration Compared to Intravenous Rehydration | Biotech Hunter | Biotech Hunter